-+ 0.00%
-+ 0.00%
-+ 0.00%

Taysha Gene Therapies Q1 EPS $(0.12) Misses $(0.10) Estimate

Benzinga·05/06/2026 12:06:15
Listen to the news
Taysha Gene Therapies (NASDAQ:TSHA) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. This is a 50 percent decrease over losses of $(0.08) per share from the same period last year.